Characterization of the Mycobacterium tuberculosis 4-Diphosphocytidyl-2- C -Methyl- d -Erythritol Synthase: Potential for Drug Development

Abstract

ABSTRACT Mycobacterium tuberculosis utilizes the methylerythritol phosphate (MEP) pathway for biosynthesis of isopentenyl diphosphate and its isomer, dimethylallyl diphosphate, precursors of all isoprenoid compounds. This pathway is of interest as a source of new drug targets, as it is absent from humans and disruption of the responsible genes has shown a lethal phenotype for Escherichia coli . In the MEP pathway, 4-diphosphocytidyl-2- C -methyl- d -erythritol is formed from 2- C -methyl- d -erythritol 4-phosphate (MEP) and CTP in a reaction catalyzed by a 4-diphosphocytidyl-2- C -methyl- d -erythritol synthase (IspD). In the present work, we demonstrate that Rv3582c is essential for M. tuberculosis : Rv3582c has been cloned and expressed, and the encoded protein has been purified. The purified M. tuberculosis IspD protein was capable of catalyzing the formation of 4-diphosphocytidyl-2- C -methyl- d -erythritol in the presence of MEP and CTP. The enzyme was active over a broad pH range (pH 6.0 to 9.0), with peak activity at pH 8.0. The activity was absolutely dependent upon divalent cations, with 20 mM Mg 2+ being optimal, and replacement of CTP with other nucleotide 5′-triphosphates did not support activity. Under the conditions tested, M. tuberculosis IspD had K m values of 58.5 μM for MEP and 53.2 μM for CTP. Calculated k cat and k cat / K m values were 0.72 min −1 and 12.3 mM −1 min −1 for MEP and 1.0 min −1 and 18.8 mM −1 min −1 for CTP, respectively.